The role of JAK-STAT signaling in adipose tissue function

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 3, 2014, Pages 431-439

  Richard, Allison J ^a   Stephens, Jacqueline M ^a,b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Brown and white adipose; Cytokine; Immune cell; Janus kinase; Obesity; Tyk2

Indexed keywords

INSULIN; JANUS KINASE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; LIPID STORAGE; NONHUMAN; OBESITY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROADIPOCYTE; REVIEW;

BROWN AND WHITE ADIPOSE; CYTOKINE; IMMUNE CELL; JANUS KINASE; OBESITY; TYK2;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ENERGY METABOLISM; GLUCOSE; HUMANS; INSULIN; JANUS KINASES; LIPID METABOLISM; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84893712870     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.05.030     Document Type: Review

References (112)

1. Altintas M.M., Azad A., Nayer B., Contreras G., Zaias J., Faul C., Reiser J., Nayer A. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J. Lipid Res. 2011, 52:480-488.
2. Ambati S., Kim H.K., Yang J.Y., Lin J., Della-Fera M.A., Baile C.A. Effects of leptin on apoptosis and adipogenesis in 3T3-L1 adipocytes. Biochem. Pharmacol. 2007, 73:378-384.
3. Athyros V.G., Tziomalos K., Karagiannis A., Anagnostis P., Mikhailidis D.P. Should adipokines be considered in the choice of the treatment of obesity-related health problems?. Curr. Drug Targets 2010, 11:122-135.
4. Balhoff J.P., Stephens J.M. Highly specific and quantitative activation of STATs in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 1998, 247:894-900.
5. Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., Maslen G.L., Williams T.D., Lewis H., Schafer A.J., Chatterjee V.K., O'Rahilly S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999, 402:880-883.
6. Baugh J.E., Floyd Z.E., Stephens J.M. The modulation of STAT5A/GR complexes during fat cell differentiation and in mature adipocytes. Obesity (Silver Spring) 2007, 15:583-590.
7. Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004, 432:324-331.
8. Boss O., Farmer S.R. Recruitment of brown adipose tissue as a therapy for obesity-associated diseases. Front. Endocrinol.(Lausanne) 2012, 3:14.
9. Brizzi M.F., Aronica M.G., Rosso A., Bagnara G.P., Yarden Y., Pegoraro L. Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J. Biol. Chem. 1996, 271:3562-3567.
10. Cernkovich E.R., Deng J., Bond M.C., Combs T.P., Harp J.B. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 2008, 149:1581-1590.
11. Cernkovich E.R., Deng J., Hua K., Harp J.B. Midkine is an autocrine activator of signal transducer and activator of transcription 3 in 3T3-L1 cells. Endocrinology 2007, 148:1598-1604.
12. Coulter A.A., Stephens J.M. STAT5 activators modulate acyl CoA oxidase (AOX) expression in adipocytes and STAT5A binds to the AOX promoter in vitro. Biochem. Biophys. Res. Commun. 2006, 344:1342-1345.
13. Cristancho A.G., Lazar M.A. Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 2011, 12:722-734.
14. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., Kuo F.C., Palmer E.L., Tseng Y.H., Doria A., Kolodny G.M., Kahn C.R. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1509-1517.
15. Defuria J., Belkina A.C., Jagannathan-Bogdan M., Snyder-Cappione J., Carr J.D., Nersesova Y.R., Markham D., Strissel K.J., Watkins A.A., Zhu M., Allen J., Bouchard J., Toraldo G., Jasuja R., Obin M.S., McDonnell M.E., Apovian C., Denis G.V., Nikolajczyk B.S. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:5133-5138.
16. Deng J., Hua K., Caveney E.J., Takahashi N., Harp J.B. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression. Biochem. Biophys. Res. Commun. 2006, 339:923-931.
17. Deng J., Hua K., Lesser S.S., Greiner A.H., Walter A.W., Marrero M.B., Harp J.B. Interleukin-4 mediates STAT6 activation in 3T3-L1 preadipocytes but not adipocytes. Biochem. Biophys. Res. Commun. 2000, 267:516-520.
18. Deng J., Hua K., Lesser S.S., Harp J.B. Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3-L1 adipogenesis. Endocrinology 2000, 141:2370-2376.
19. Derecka M., Gornicka A., Koralov S.B., Szczepanek K., Morgan M., Raje V., Sisler J., Zhang Q., Otero D., Cichy J., Rajewsky K., Shimoda K., Poli V., Strobl B., Pellegrini S., Harris T.E., Seale P., Russell A.P., McAinch A.J., O'Brien P.E., Keller S.R., Croniger C.M., Kordula T., Larner A.C. Tyk2 and stat3 regulate brown adipose tissue differentiation and obesity. Cell Metab. 2012, 16:814-824.
20. Doerrler W., Feingold K.R., Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 1994, 6:478-484.
21. Doyle S.E., Gasson J.C. Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5. Blood 1998, 92:867-876.
22. Duffaut C., Zakaroff-Girard A., Bourlier V., Decaunes P., Maumus M., Chiotasso P., Sengenes C., Lafontan M., Galitzky J., Bouloumie A. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1608-1614.
23. Farmer S.R. Molecular determinants of brown adipocyte formation and function. Genes Dev. 2008, 22:1269-1275.
24. Fleenor D., Arumugam R., Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm. Res. 2006, 66:101-110.
25. Flint D.J., Binart N., Kopchick J., Kelly P. Effects of growth hormone and prolactin on adipose tissue development and function. Pituitary 2003, 6:97-102.
26. Floyd Z.E., Stephens J.M. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J. Biol. Chem. 2002, 277:4062-4068.
27. Floyd Z.E., Stephens J.M. STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes 2003, 52:308-314.
28. Furuhashi M., Fucho R., Gorgun C.Z., Tuncman G., Cao H., Hotamisligil G.S. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J. Clin. Invest. 2008, 118:2640-2650.
29. Furuhashi M., Tuncman G., Gorgun C.Z., Makowski L., Atsumi G., Vaillancourt E., Kono K., Babaev V.R., Fazio S., Linton M.F., Sulsky R., Robl J.A., Parker R.A., Hotamisligil G.S. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007, 447:959-965.
30. Gregoire F., De B.N., Hauser N., Heremans H., Van D.J., Remacle C. Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J. Cell. Physiol. 1992, 151:300-309.
31. Hamann A., Flier J.S., Lowell B.B. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 1996, 137:21-29.
32. Harp J.B., Franklin D., Vanderpuije A.A., Gimble J.M. Differential expression of signal transducers and activators of transcription during human adipogenesis. Biochem. Biophys. Res. Commun. 2001, 281:907-912.
33. Hellgren G., Albertsson-Wikland K., Billig H., Carlsson L.M., Carlsson B. Growth hormone receptor interaction with Jak proteins differs between tissues. J. Interferon Cytokine Res. 2001, 21:75-83.
34. Hogan J.C., Stephens J.M. The identification and characterization of a STAT 1 binding site in the PPARgamma2 promoter. Biochem. Biophys. Res. Commun. 2001, 287:484-492.
35. Hogan J.C., Stephens J.M. STAT 1 binds to the LPL promoter in vitro. Biochem. Biophys. Res. Commun. 2003, 307:350-354.
36. Hogan J.C., Stephens J.M. The regulation of fatty acid synthase by STAT5A. Diabetes 2005, 54:1968-1975.
37. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15:3059-3087.
38. Jung H.S., Lee Y.J., Kim Y.H., Paik S., Kim J.W., Lee J.W. Peroxisome proliferator-activated receptor gamma/signal transducers and activators of transcription 5A pathway plays a key factor in adipogenesis of human bone marrow-derived stromal cells and 3T3-L1 preadipocytes. Stem Cells Dev. 2012, 21:465-475.
39. Kawai M., Namba N., Mushiake S., Etani Y., Nishimura R., Makishima M., Ozono K. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J. Mol. Endocrinol. 2007, 38:19-34.
40. Keay S., Grossberg S.E. Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:4099-4103.
41. Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N., Zhang B.B., Bonaldo P., Chua S., Scherer P.E. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 2009, 29:1575-1591.
42. Kim D.H., Sandoval D., Reed J.A., Matter E.K., Tolod E.G., Woods S.C., Seeley R.J. The role of GM-CSF in adipose tissue inflammation. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1038-E1046.
43. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., Schraw T., Durand J.L., Li H., Li G., Jelicks L.A., Mehler M.F., Hui D.Y., Deshaies Y., Shulman G.I., Schwartz G.J., Scherer P.E. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
44. Kisseleva T., Bhattacharya S., Braunstein J., Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002, 285:1-24.
45. Klaus S., Munzberg H., Truloff C., Heldmaier G. Physiology of transgenic mice with brown fat ablation: obesity is due to lowered body temperature. Am. J. Physiol. 1998, 274:R287-R293.
46. Koivisto V.A., Pelkonen R., Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 1989, 38:641-647.
47. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R., Ferrante A.W. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 2010, 120:3466-3479.
48. Lee J.Y., Muenzberg H., Gavrilova O., Reed J.A., Berryman D., Villanueva E.C., Louis G.W., Leinninger G.M., Bertuzzi S., Seeley R.J., Robinson G.W., Myers M.G., Hennighausen L. Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PLoS One 2008, 3:e1639.
49. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
50. Liu J., Divoux A., Sun J., Zhang J., Clement K., Glickman J.N., Sukhova G.K., Wolters P.J., Du J., Gorgun C.Z., Doria A., Libby P., Blumberg R.S., Kahn B.B., Hotamisligil G.S., Shi G.P. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009, 15:940-945.
51. Machinal-Quelin F., Dieudonne M.N., Leneveu M.C., Pecquery R., Giudicelli Y. Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways. Am. J. Physiol. Cell Physiol. 2002, 282:C853-C863.
52. Mathis D., Shoelson S.E. Immunometabolism: an emerging frontier. Nat. Rev. Immunol. 2011, 11:81.
53. McGillicuddy F.C., Chiquoine E.H., Hinkle C.C., Kim R.J., Shah R., Roche H.M., Smyth E.M., Reilly M.P. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 2009, 284:31936-31944.
54. McGillicuddy F.C., Harford K.A., Reynolds C.M., Oliver E., Claessens M., Mills K.H., Roche H.M. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 2011, 60:1688-1698.
55. Meirhaeghe A., Fajas L., Gouilleux F., Cottel D., Helbecque N., Auwerx J., Amouyel P. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler. Thromb. Vasc. Biol. 2003, 23:289-294.
56. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M., Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84:431-442.
57. Miyaoka Y., Tanaka M., Naiki T., Miyajima A. Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J. Biol. Chem. 2006, 281:37913-37920.
58. Mlinar B., Marc J. New insights into adipose tissue dysfunction in insulin resistance. Clin. Chem. Lab. Med. 2011, 49:1925-1935.
59. Mui A.L., Wakao H., O'Farrell A.M., Harada N., Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 1995, 14:1166-1175.
60. Nanbu-Wakao R., Fujitani Y., Masuho Y., Muramatu M., Wakao H. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol. Endocrinol. 2000, 14:307-316.
61. Nanbu-Wakao R., Morikawa Y., Matsumura I., Masuho Y., Muramatsu M.A., Senba E., Wakao H. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Mol. Endocrinol. 2002, 16:1565-1576.
62. Nedergaard J., Bengtsson T., Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E444-E452.
63. Nguyen K.D., Qiu Y., Cui X., Goh Y.P., Mwangi J., David T., Mukundan L., Brombacher F., Locksley R.M., Chawla A. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011, 480:104-108.
64. O'Rourke R.W., Metcalf M.D., White A.E., Madala A., Winters B.R., Maizlin I.I., Jobe B.A., Roberts C.T., Slifka M.K., Marks D.L. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int. J. Obes. (Lond.) 2009, 33:978-990.
65. O'Rourke R.W., White A.E., Metcalf M.D., Winters B.R., Diggs B.S., Zhu X., Marks D.L. Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metabolism 2012, 61:1152-1161.
66. Ott V., Fasshauer M., Dalski A., Klein H.H., Klein J. Direct effects of ciliary neurotrophic factor on brown adipocytes: evidence for a role in peripheral regulation of energy homeostasis. J. Endocrinol. 2002, 173:R1-R8.
67. Pelton P.D., Zhou L., Demarest K.T., Burris T.P. PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem. Biophys. Res. Commun. 1999, 261:456-458.
68. Pfitzner E., Kliem S., Baus D., Litterst C.M. The role of STATs in inflammation and inflammatory diseases. Curr. Pharm. Des. 2004, 10:2839-2850.
69. Pospisilik J.A., Schramek D., Schnidar H., Cronin S.J., Nehme N.T., Zhang X., Knauf C., Cani P.D., Aumayr K., Todoric J., Bayer M., Haschemi A., Puviindran V., Tar K., Orthofer M., Neely G.G., Dietzl G., Manoukian A., Funovics M., Prager G., Wagner O., Ferrandon D., Aberger F., Hui C.C., Esterbauer H., Penninger J.M. Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell 2010, 140:148-160.
70. Richter H.E., Albrektsen T., Billestrup N. The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation. J. Mol. Endocrinol. 2003, 30:139-150.
71. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., Libby P. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 2008, 103:467-476.
72. Romeo G.R., Lee J., Shoelson S.E. Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1771-1776.
73. Rosen R.L., Winestock K.D., Chen G., Liu X., Hennighausen L., Finbloom D.S. Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes. Blood 1996, 88:1206-1214.
74. Sanchez-Gurmaches J., Hung C.M., Sparks C.A., Tang Y., Li H., Guertin D.A. PTEN loss in the Myf5 lineage redistributes body fat and reveals subsets of white adipocytes that arise from Myf5 precursors. Cell Metab. 2012, 16:348-362.
75. Sarjeant K., Stephens J.M. Adipogenesis, Cold Spring Harb. Perspect. Biol. 2012, 4.
76. Schindler C., Darnell J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 1995, 64:621-651.
77. Schipper H.S., Prakken B., Kalkhoven E., Boes M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol. Metab. 2012, 23:407-415.
78. Seale P., Bjork B., Yang W., Kajimura S., Chin S., Kuang S., Scime A., Devarakonda S., Conroe H.M., Erdjument-Bromage H., Tempst P., Rudnicki M.A., Beier D.R., Spiegelman B.M. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454:961-967.
79. Shang C.A., Waters M.J. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol. Endocrinol. 2003, 17:2494-2508.
80. Shiba T., Higashi N., Nishimura Y. Hyperglycaemia due to insulin resistance caused by interferon-gamma. Diabet. Med. 1998, 15:435-436.
81. Siegrist-Kaiser C.A., Pauli V., Juge-Aubry C.E., Boss O., Pernin A., Chin W.W., Cusin I., Rohner-Jeanrenaud F., Burger A.G., Zapf J., Meier C.A. Direct effects of leptin on brown and white adipose tissue. J. Clin. Invest. 1997, 100:2858-2864.
82. Siersbaek R., Nielsen R., John S., Sung M.H., Baek S., Loft A., Hager G.L., Mandrup S. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 2011, 30:1459-1472.
83. Song H.Y., Jeon E.S., Kim J.I., Jung J.S., Kim J.H. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. J. Cell. Biochem. 2007, 101:1238-1251.
84. Stark G.R., Darnell J.E. The JAK-STAT pathway at twenty. Immunity 2012, 36:503-514.
85. Stephens J.M., Lumpkin S.J., Fishman J.B. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J. Biol. Chem. 1998, 273:31408-31416.
86. Stephens J.M., Morrison R.F., Pilch P.F. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J. Biol. Chem. 1996, 271:10441-10444.
87. Stewart W.C., Baugh J.E., Floyd Z.E., Stephens J.M. STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 2004, 324:355-359.
88. Stewart W.C., Morrison R.F., Young S.L., Stephens J.M. Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: coordinate regulation of STATs 1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma and C/AAAT enhancer binding protein-alpha. Biochim. Biophys. Acta 1999, 1452:188-196.
89. Stewart W.C., Pearcy L.A., Floyd Z.E., Stephens J.M. STAT5A expression in Swiss 3T3 cells promotes adipogenesis in vivo in an athymic mice model system. Obesity (Silver Spring) 2011, 19:1731-1734.
90. Story D.J., Stephens J.M. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes. Obesity (Silver Spring) 2006, 14:1303-1311.
91. Strissel K.J., DeFuria J., Shaul M.E., Bennett G., Greenberg A.S., Obin M.S. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010, 18:1918-1925.
92. Suh J.M., Gao X., McKay J., McKay R., Salo Z., Graff J.M. Hedgehog signaling plays a conserved role in inhibiting fat formation. Cell Metab. 2006, 3:25-34.
93. Talukdar S., Oh d.Y., Bandyopadhyay G., Li D., Xu J., McNelis J., Lu M., Li P., Yan Q., Zhu Y., Ofrecio J., Lin M., Brenner M.B., Olefsky J.M. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 2012, 18:1407-1412.
94. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
95. Thompson B.R., Mazurkiewicz-Munoz A.M., Suttles J., Carter-Su C., Bernlohr D.A. Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling. J. Biol. Chem. 2009, 284:13473-13480.
96. Todoric J., Strobl B., Jais A., Boucheron N., Bayer M., Amann S., Lindroos J., Teperino R., Prager G., Bilban M., Ellmeier W., Krempler F., Muller M., Wagner O., Patsch W., Pospisilik J.A., Esterbauer H. Cross-talk between interferon-gamma and hedgehog signaling regulates adipogenesis. Diabetes 2011, 60:1668-1676.
97. Urs S., Harrington A., Liaw L., Small D. Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Transgenic Res. 2006, 15:647-653.
98. Varjosalo M., Taipale J. Hedgehog: functions and mechanisms. Genes Dev. 2008, 22:2454-2472.
99. Waite K.J., Floyd Z.E., Arbour-Reily P., Stephens J.M. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J. Biol. Chem. 2001, 276:7062-7068.
100. Wakao H., Wakao R., Oda A., Fujita H. Constitutively active Stat5A and Stat5B promote adipogenesis. Environ. Health Prev. Med. 2011, 16:247-252.
101. Wang D., Zhou Y., Lei W., Zhang K., Shi J., Hu Y., Shu G., Song J. Signal transducer and activator of transcription 3 (STAT3) regulates adipocyte differentiation via peroxisome-proliferator-activated receptor gamma (PPARgamma). Biol. Cell 2010, 102:1-12.
102. Watanabe S., Itoh T., Arai K. JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J. Biol. Chem. 1996, 271:12681-12686.
103. White U.A., Coulter A.A., Miles T.K., Stephens J.M. The STAT5A-mediated induction of pyruvate dehydrogenase kinase 4 expression by prolactin or growth hormone in adipocytes. Diabetes 2007, 56:1623-1629.
104. White U.A., Stephens J.M. Transcriptional factors that promote formation of white adipose tissue. Mol. Cell. Endocrinol. 2010, 318:10-14.
105. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., Leong H.X., Glassford A., Caimol M., Kenkel J.A., Tedder T.F., McLaughlin T., Miklos D.B., Dosch H.M., Engleman E.G. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17:610-617.
106. Xiao W., Hong H., Kawakami Y., Lowell C.A., Kawakami T. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. J. Clin. Invest. 2008, 118:924-934.
107. Yang H., Youm Y.H., Vandanmagsar B., Ravussin A., Gimble J.M., Greenway F., Stephens J.M., Mynatt R.L., Dixit V.D. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 2010, 185:1836-1845.
108. Yarwood S.J., Sale E.M., Sale G.J., Houslay M.D., Kilgour E., Anderson N.G. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. J. Biol. Chem. 1999, 274:8662-8668.
109. Zhang K., Guo W., Yang Y., Wu J. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPbeta transcription. J. Cell. Biochem. 2011, 112:488-497.
110. Zvonic S., Cornelius P., Stewart W.C., Mynatt R.L., Stephens J.M. The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. J. Biol. Chem. 2003, 278:2228-2235.
111. Zvonic S., Hogan J.C., Arbour-Reily P., Mynatt R.L., Stephens J.M. Effects of cardiotrophin on adipocytes. J. Biol. Chem. 2004, 279:47572-47579.
112. Zvonic S., Story D.J., Stephens J.M., Mynatt R.L. Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo. Biochem. Biophys. Res. Commun. 2003, 302:359-362.